XERS logo

Xeris Biopharma Holdings (XERS) EBIT

Annual EBIT

-$26.62 M
+$10.28 M+27.85%

December 1, 2024

Summary

Performance

1-Year Change

+27.85%

3-Year Change

+76.96%

5-Year Change

+77.61%

15-Year Change

-0.25%

XERS EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

48.14%
XERS annual earnings before interest & taxes is higher than 48.14% of companies in Healthcare sector

High & Low

All-time High

-$13.21 M

3-Year Low

-$115.55 M

Earnings dates

Last Annual Earnings Report Date

Dec 1, 2024
XERS previous annual earnings announcement was published on Dec 1, 2024

Next Annual Earnings Report Date

N/A
XERS next annual earnings announcement has not yet been scheduled

OtherXERSprofitabilitymetrics:

Annual Revenue

$203.07 M
XERS annual revenue is $203.07 million

Annual Net Income

-$54.84 M
XERS annual net profit is -$54.84 million

Annual EBITDA

-$13.99 M
XERS annual EBITDA is -$13.99 million

Annual EPS

-$0.37
XERS annual earnings per share is -$0.37

Quarterly EBIT

$2.59 M
+$13.87 M+122.97%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

+145.6%

5-Year Change

+145.6%

XERS Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

81.24%
XERS quarterly earnings before interest & taxes is higher than 81.24% of companies in Healthcare sector

High & Low

All-time High

$2.59 M
XERS quarterly earnings before interest & taxes is currently at an all-time high

3-Year Low

-$48.99 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
XERS previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 9, 2025
XERS next earnings announcement is scheduled for May 9, 2025

OtherXERSprofitabilitymetrics:

Quarterly Revenue

$60.10 M
XERS quarterly revenue is $60.10 million

Quarterly Net Income

-$5.11 M
XERS quarterly net profit is -$5.11 million

Quarterly EBITDA

$5.72 M
XERS quarterly EBITDA is $5.72 million

Quarterly EPS

-$0.03
XERS quarterly earnings per share is -$0.03

TTM EBIT

-$26.62 M
+$9.20 M+25.68%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

+32.07%

5-Year Change

+32.07%

XERS TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

47.74%
XERS TTM earnings before interest & taxes is higher than 47.74% of companies in Healthcare sector

High & Low

All-time High

-$4.65 M

3-Year Low

-$129.53 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
XERS previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 9, 2025
XERS next earnings announcement is scheduled for May 9, 2025

OtherXERSprofitabilitymetrics:

TTM Revenue

$203.07 M
XERS TTM revenue is $203.07 million

TTM Net Income

-$54.84 M
XERS TTM net profit is -$54.84 million

TTM EBITDA

-$13.99 M
XERS TTM EBITDA is -$13.99 million

TTM EPS

-$0.38
XERS TTM earnings per share is -$0.38

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

Annual EBIT

-$26.62 M
XERS annual earnings before interest & taxes is -$26.62 million

Annual Revenue

$203.07 M
XERS annual revenue is $203.07 million

Annual Cost Of Goods Sold

$36.83 M
XERS annual cost of goods sold is $36.83 million

Annual Operating Expenses

$199.88 M
XERS annual total operating expenses is $199.88 million

XERS EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+27.9%0.0%0.0%
3 y3 years+77.0%+145.6%+32.1%
5 y5 years+77.6%+145.6%+32.1%

XERS EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+77.0%at high+105.3%at high+79.5%
5 y5-yearat high+77.6%at high+105.3%at high+79.5%
alltimeall time-101.5%+77.6%at high+105.3%-472.6%+79.5%

Xeris Biopharma Holdings EBIT History

DateAnnualQuarterlyTTM
Dec 2024
-
$2.59 M(-123.0%)
-$26.62 M(-25.7%)
Dec 2024
-$26.62 M(-27.9%)
-
-
Sep 2024
-
-$11.28 M(+79.2%)
-$35.82 M(+18.5%)
Jun 2024
-
-$6.29 M(-45.9%)
-$30.22 M(-20.3%)
Mar 2024
-
-$11.64 M(+76.2%)
-$37.92 M(+2.8%)
Dec 2023
-$36.90 M(-55.0%)
-$6.61 M(+16.3%)
-$36.90 M(-5.9%)
Sep 2023
-
-$5.68 M(-59.4%)
-$39.19 M(-24.2%)
Jun 2023
-
-$13.99 M(+31.7%)
-$51.69 M(-15.0%)
Mar 2023
-
-$10.62 M(+19.3%)
-$60.78 M(-24.7%)
Dec 2022
-$81.98 M(-29.0%)
-$8.90 M(-51.0%)
-$80.76 M(-33.2%)
Sep 2022
-
-$18.18 M(-21.2%)
-$120.85 M(-4.8%)
Jun 2022
-
-$23.08 M(-24.6%)
-$126.88 M(-2.0%)
Mar 2022
-
-$30.60 M(-37.5%)
-$129.53 M(+12.1%)
Dec 2021
-$115.55 M(+43.4%)
-$48.99 M(+102.4%)
-$115.55 M(+37.9%)
Sep 2021
-
-$24.21 M(-5.9%)
-$83.82 M(+14.4%)
Jun 2021
-
-$25.72 M(+54.8%)
-$73.28 M(+5.4%)
Mar 2021
-
-$16.62 M(-3.7%)
-$69.53 M(-13.7%)
DateAnnualQuarterlyTTM
Dec 2020
-$80.59 M(-32.2%)
-$17.27 M(+26.3%)
-$80.59 M(-15.5%)
Sep 2020
-
-$13.67 M(-37.8%)
-$95.33 M(-14.1%)
Jun 2020
-
-$21.97 M(-20.7%)
-$110.99 M(-9.3%)
Mar 2020
-
-$27.68 M(-13.5%)
-$122.35 M(+2.9%)
Dec 2019
-$118.88 M(+106.6%)
-$32.01 M(+9.1%)
-$118.88 M(+11.9%)
Sep 2019
-
-$29.33 M(-12.0%)
-$106.23 M(+16.8%)
Jun 2019
-
-$33.32 M(+37.6%)
-$90.93 M(+29.8%)
Mar 2019
-
-$24.21 M(+25.0%)
-$70.03 M(+21.7%)
Dec 2018
-$57.53 M(+116.7%)
-$19.36 M(+38.0%)
-$57.53 M(+21.6%)
Sep 2018
-
-$14.03 M(+12.9%)
-$47.32 M(+15.9%)
Jun 2018
-
-$12.43 M(+6.1%)
-$40.81 M(+21.4%)
Mar 2018
-
-$11.72 M(+28.1%)
-$33.62 M(+26.6%)
Dec 2017
-$26.55 M(+101.0%)
-$9.14 M(+21.5%)
-$26.55 M(+52.5%)
Sep 2017
-
-$7.53 M(+43.9%)
-$17.41 M(+76.2%)
Jun 2017
-
-$5.23 M(+12.5%)
-$9.88 M(+112.5%)
Mar 2017
-
-$4.65 M
-$4.65 M
Dec 2016
-$13.21 M
-
-

FAQ

  • What is Xeris Biopharma Holdings annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Xeris Biopharma Holdings?
  • What is Xeris Biopharma Holdings annual EBIT year-on-year change?
  • What is Xeris Biopharma Holdings quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Xeris Biopharma Holdings?
  • What is Xeris Biopharma Holdings quarterly EBIT year-on-year change?
  • What is Xeris Biopharma Holdings TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Xeris Biopharma Holdings?
  • What is Xeris Biopharma Holdings TTM EBIT year-on-year change?

What is Xeris Biopharma Holdings annual earnings before interest & taxes?

The current annual EBIT of XERS is -$26.62 M

What is the all time high annual EBIT for Xeris Biopharma Holdings?

Xeris Biopharma Holdings all-time high annual earnings before interest & taxes is -$13.21 M

What is Xeris Biopharma Holdings annual EBIT year-on-year change?

Over the past year, XERS annual earnings before interest & taxes has changed by +$10.28 M (+27.85%)

What is Xeris Biopharma Holdings quarterly earnings before interest & taxes?

The current quarterly EBIT of XERS is $2.59 M

What is the all time high quarterly EBIT for Xeris Biopharma Holdings?

Xeris Biopharma Holdings all-time high quarterly earnings before interest & taxes is $2.59 M

What is Xeris Biopharma Holdings quarterly EBIT year-on-year change?

Over the past year, XERS quarterly earnings before interest & taxes has changed by $0.00 (0.00%)

What is Xeris Biopharma Holdings TTM earnings before interest & taxes?

The current TTM EBIT of XERS is -$26.62 M

What is the all time high TTM EBIT for Xeris Biopharma Holdings?

Xeris Biopharma Holdings all-time high TTM earnings before interest & taxes is -$4.65 M

What is Xeris Biopharma Holdings TTM EBIT year-on-year change?

Over the past year, XERS TTM earnings before interest & taxes has changed by $0.00 (0.00%)